Differential properties of E prostanoid receptor-3 and thromboxane prostanoid receptor in activation by prostacyclin to evoke vasoconstrictor response in the mouse renal vasculature.
Animals
Epoprostenol
/ pharmacology
Kidney
/ drug effects
Male
Mice
Mice, Inbred C57BL
Prostaglandins
/ metabolism
Prostaglandins I
/ pharmacology
Receptors, Prostaglandin E, EP3 Subtype
/ metabolism
Receptors, Thromboxane
/ metabolism
Renal Artery
/ drug effects
Vasoconstriction
/ drug effects
Vasoconstrictor Agents
/ pharmacology
EP3
IP
PGI2
TP
renal vasoresponse
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484
Informations de publication
Date de publication:
12 2020
12 2020
Historique:
received:
09
04
2020
revised:
16
09
2020
accepted:
28
09
2020
pubmed:
14
10
2020
medline:
24
4
2021
entrez:
13
10
2020
Statut:
ppublish
Résumé
Vasomotor reactions of prostacyclin (prostaglandin I
Identifiants
pubmed: 33047360
doi: 10.1096/fj.202000845RR
doi:
Substances chimiques
Prostaglandins
0
Prostaglandins I
0
Ptger3 protein, mouse
0
Receptors, Prostaglandin E, EP3 Subtype
0
Receptors, Thromboxane
0
Vasoconstrictor Agents
0
Epoprostenol
DCR9Z582X0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16105-16116Informations de copyright
© 2020 Federation of American Societies for Experimental Biology.
Références
Bunting S, Gryglewski R, Moncada S, Vane JR. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation. Prostaglandins. 1976;12:897-913.
Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978;47:997-1029.
Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79:1193-1226.
Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem. 2000;69:145-182.
Davidge ST. Prostaglandin H synthase and vascular function. Circ Res. 2001;89:650-660.
Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol. 2008;93:141-147.
Needleman P, Moncada S, Bunting S, Vane JR, Hamberg M, Samuelsson B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976;261:558-560.
Dusting GJ, Moncada S, Vane JR. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig. Eur J Pharmacol. 1977;45:301-304.
Gluais P, Lonchampt M, Morrow JD, Vanhoutte PM, Feletou M. Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol. 2005;146:834-845.
Levy JV. Contractile responses to prostacyclin (PGI2) of isolated human saphenous and rat venous tissue. Prostaglandins. 1978;16:93-97.
Liu B, Luo W, Zhang Y, et al. Involvement of cyclo-oxygenase-1-mediated prostacyclin synthesis in the vasoconstrictor activity evoked by ACh in mouse arteries. Exp Physiol. 2012;97:277-289.
Williams SP, Dorn GW 2nd, Rapoport RM. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle. Am J Physiol. 1994;267:H796-H803.
Levy JV. Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR). Prostaglandins. 1980;19:517-525.
Zhao YJ, Wang J, Tod ML, Rubin LJ, Yuan XJ. Pulmonary vasoconstrictor effects of prostacyclin in rats: potential role of thromboxane receptors. J Appl Physiol. 1996;81:2595-2603.
Li Z, Zhang Y, Liu B, Luo W, Li H, Zhou Y. Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice. Sci Rep. 2017;7:42167.
Liu B, Luo W, Zhang Y, et al. Concomitant activation of functionally opposing prostacyclin and thromboxane prostanoid receptors by cyclo-oxygenase-1-mediated prostacyclin synthesis in mouse arteries. Exp Physiol. 2012;97:895-904.
Liu B, Zhan M, Zhang Y, et al. Increased role of E prostanoid receptor-3 in prostacyclin-evoked contractile activity of spontaneously hypertensive rat mesenteric resistance arteries. Sci Rep. 2017;7:8927.
Luo W, Liu B, Zhou Y. The endothelial cyclooxygenase pathway: Insights from mouse arteries. Eur J Pharmacol. 2016;780:148-158.
Hu C, Liu B, Xu Y, et al. EP3 blockade adds to the effect of TP deficiency in alleviating endothelial dysfunction in atherosclerotic mouse aortas. Front Physiol. 2019;10:1247.
Liu D, Liu B, Luo W, Li H, Zhang Y, Zhou Y. A vasoconstrictor response to COX-1-mediated prostacyclin synthesis in young rat renal arteries that increases in prehypertensive conditions. Am J Physiol Heart Circ Physiol. 2015;309:H804-H811.
Liu B, Luo W, Zhang Y, et al. Role of cyclooxygenase-1-mediated prostacyclin synthesis in endothelium-dependent vasoconstrictor activity of porcine interlobular renal arteries. Am J Physiol Renal Physiol. 2012;302:F1133-F1140.
Liu B, Zhang Y, Zhu N, Li H, Luo W, Zhou Y. A vasoconstrictor role for cyclooxygenase-1-mediated prostacyclin synthesis in mouse renal arteries. Am J Physiol Renal Physiol. 2013;305(9):F1315-F1322.
Blanco-Rivero J, Cachofeiro V, Lahera V, et al. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension. 2005;46:107-112.
Rapoport RM, Williams SP. Role of prostaglandins in acetylcholine-induced contraction of aorta from spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1996;28:64-75.
Vanhoutte PM. Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension. 2011;57:526-531.
Feletou M, Verbeuren TJ, Vanhoutte PM. Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol. 2009;156:563-574.
Xavier FE, Aras-Lopez R, Arroyo-Villa I, et al. Aldosterone induces endothelial dysfunction in resistance arteries from normotensive and hypertensive rats by increasing thromboxane A2 and prostacyclin. Br J Pharmacol. 2008;154:1225-1235.
Eskildsen MP, Hansen PB, Stubbe J, et al. Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors. Hypertension. 2014;64:551-556.
Liu B, Li J, Yan H, et al. TP and/or EP3 receptors mediate the vasoconstrictor and pressor responses of prostaglandin F2alpha in mice and/or humans. FASEB J. 2019;33:2451-2459.
Liu B, Wu X, Zeng R, et al. Prostaglandin E2 sequentially activates E-prostanoid receptor-3 and thromboxane prostanoid receptor to evoke contraction and increase in resistance of the mouse renal vasculature. FASEB J. 2020;34:2568-2578.
Kirkby NS, Lundberg MH, Harrington LS, et al. Cyclooxygenase-1, not cyclooxygenase-2, is responsible for physiological production of prostacyclin in the cardiovascular system. Proc Natl Acad Sci U S A. 2012;109:17597-17602.
Zhou Y, Varadharaj S, Zhao X, Parinandi N, Flavahan NA, Zweier JL. Acetylcholine causes endothelium-dependent contraction of mouse arteries. Am J Physiol Heart Circ Physiol. 2005;289:H1027-H1032.
Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
Tang EH, Jensen BL, Skott O, et al. The role of prostaglandin E and thromboxane-prostanoid receptors in the response to prostaglandin E2 in the aorta of Wistar Kyoto rats and spontaneously hypertensive rats. Cardiovasc Res. 2008;78:130-138.
Hao CM, Breyer MD. Physiological regulation of prostaglandins in the kidney. Annu Rev Physiol. 2008;70:357-377.
Nasrallah R, Hebert RL. Prostacyclin signaling in the kidney: implications for health and disease. Am J Physiol Renal Physiol. 2005;289:F235-F246.
Ihara E, Hirano K, Derkach DN, Nishimura J, Nawata H, Kanaide H. The mechanism of bradykinin-induced endothelium-dependent contraction and relaxation in the porcine interlobar renal artery. Br J Pharmacol. 2000;129:943-952.
Scotland RS, Madhani M, Chauhan S, et al. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo. Circulation. 2005;111:796-803.
Li S, Liu B, Luo W, et al. Role of cyclooxygenase-1 and -2 in endothelium-dependent contraction of atherosclerotic mouse abdominal aortas. Clin Exp Pharmacol Physiol. 2016;43:67-74.
Liu B, Li Z, Zhang Y, et al. Vasomotor reaction to cyclooxygenase-1-mediated prostacyclin synthesis in carotid arteries from two-kidney-one-clip hypertensive mice. PLoS One. 2015;10:e0136738.
Zhu N, Liu B, Luo W, et al. Vasoconstrictor role of cyclooxygenase-1-mediated prostacyclin synthesis in non-insulin-dependent diabetic mice induced by high-fat diet and streptozotocin. Am J Physiol Heart Circ Physiol. 2014;307:H319-H327.
Wong SL, Leung FP, Lau CW, et al. Cyclooxygenase-2-derived prostaglandin F2alpha mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res. 2009;104:228-235.
Longrois D, Gomez I, Foudi N, et al. Prostaglandin E(2) induced contraction of human intercostal arteries is mediated by the EP(3) receptor. Eur J Pharmacol. 2012;681:55-59.
Norel X, de Montpreville V, Brink C. Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713. Prostaglandins Other Lipid Mediat. 2004;74:101-112.
Benyahia C, Boukais K, Gomez I, et al. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor. Prostaglandins Other Lipid Mediat. 2013;107:48-55.
Norel X, Walch L, Gascard JP, deMontpreville V, Brink C. Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone. Br J Pharmacol. 2004;142:788-796.
Vachiery JL. Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy. Adv Ther. 2011;28:251-269.
Dzeshka MS, Shantsila A, Lip GY. Effects of aspirin on endothelial function and hypertension. Curr Hypertens Rep. 2016;18:83.
Meurer M, Ebert K, Schweda F, Hocherl K. The renal vasodilatory effect of prostaglandins is ameliorated in isolated-perfused kidneys of endotoxemic mice. Pflugers Arch. 2018;470:1691-1703.
Michel F, Simonet S, Vayssettes-Courchay C, et al. Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice. Am J Physiol Renal Physiol. 2008;294:F120-F129.
Kirkby NS, Sampaio W, Etelvino G, et al. Cyclooxygenase-2 selectively controls renal blood flow through a novel PPARbeta/delta-dependent vasodilator pathway. Hypertension. 2018;71:297-305.
Yu H, Carretero OA, Juncos LA, Garvin JL. Biphasic effect of bradykinin on rabbit afferent arterioles. Hypertension. 1998;32:287-292.
Dai FX, Skopec J, Diederich A, Diederich D. Prostaglandin H2 and thromboxane A2 are contractile factors in intrarenal arteries of spontaneously hypertensive rats. Hypertension. 1992;19:795-798.
Schor N, Brenner BM. Possible mechanism of prostaglandin-induced renal vasoconstriction in the rat. Hypertension. 1981;3:81-85.
van Rodijnen WF, Korstjens IJ, Legerstee N, Ter Wee PM, Tangelder GJ. Direct vasoconstrictor effect of prostaglandin E2 on renal interlobular arteries: role of the EP3 receptor. Am J Physiol Renal Physiol. 2007;292:F1094-F1101.
Inscho EW, Carmines PK, Navar LG. Prostaglandin influences on afferent arteriolar responses to vasoconstrictor agonists. Am J Physiol. 1990;259:F157-F163.